» Articles » PMID: 3147152

The Inhibitory Effects of Mycobacterial Lipoarabinomannan and Polysaccharides Upon Polyclonal and Monoclonal Human T Cell Proliferation

Overview
Date 1988 Nov 1
PMID 3147152
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Lipoarabinomannan from Mycobacterium tuberculosis was able to inhibit antigen induced T cell proliferation of human CD4+ T cell clones specific for influenza virus. The inhibitory effect was also present when peripheral human T cells were stimulated with crude mycobacterial antigen extracts. Non-specific T cell stimulation, i.e. IL-2, PHA and anti-CD3 antibodies coupled to beads, was not affected. The inhibitory property was also found when arabinomannan and arabinogalactan of mycobacterial origin were tested but not with other unrelated polysaccharides used as controls. The effect appears to be related to the processing of the antigen by the antigen-presenting cells, since it was evident when T cell clones were stimulated with whole virus, whereas stimulation with a synthetic peptide containing the relevant epitope was not inhibitable.

Citing Articles

Collected Thoughts on Mycobacterial Lipoarabinomannan, a Cell Envelope Lipoglycan.

Torrelles J, Chatterjee D Pathogens. 2023; 12(11).

PMID: 38003746 PMC: 10675199. DOI: 10.3390/pathogens12111281.


Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of through induction of autophagy and augment anti-TB activity of isoniazid in RAW 264.7 macrophages.

Gupta P, Jahagirdar P, Tripathi D, Devarajan P, Kulkarni S Front Immunol. 2023; 14:1233630.

PMID: 37583694 PMC: 10424441. DOI: 10.3389/fimmu.2023.1233630.


Immunological hyporesponsiveness in tuberculosis: The role of mycobacterial glycolipids.

Correia-Neves M, Nigou J, Mousavian Z, Sundling C, Kallenius G Front Immunol. 2022; 13:1035122.

PMID: 36544778 PMC: 9761185. DOI: 10.3389/fimmu.2022.1035122.


Detection of the tuberculosis biomarker mannose-capped lipoarabinomannan in human serum: Impact of sample pretreatment with perchloric acid.

Owens N, Young C, Laurentius L, De P, Chatterjee D, Porter M Anal Chim Acta. 2018; 1046:140-147.

PMID: 30482291 PMC: 6275550. DOI: 10.1016/j.aca.2018.09.037.


Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Turner J, Torrelles J Pathog Dis. 2018; 76(4).

PMID: 29722821 PMC: 5930247. DOI: 10.1093/femspd/fty026.


References
1.
Moreno C, Courtenay B, Howard J . Molecular size and structure in relation to the tolerogenicity of small fructosans (levans). Immunochemistry. 1976; 13(5):429-35. DOI: 10.1016/0019-2791(76)90379-7. View

2.
Misaki A, Azuma I, Yamamura Y . Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J Biochem. 1977; 82(6):1759-70. DOI: 10.1093/oxfordjournals.jbchem.a131874. View

3.
Moreno C, Hale C, Ivanyi L . The mitogenic, immunogenic and tolerogenic properties of dextrans and levans. Lack of correlation according to differences of molecular structure and size. Immunology. 1977; 33(2):261-7. PMC: 1445345. View

4.
Ellner J, Daniel T . Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol. 1979; 35(2):250-7. PMC: 1537646. View

5.
Weber P, Gray G . Structural and immunochemical characterization of the acidic arabinomannan of Mycobacterium smegmatis. Carbohydr Res. 1979; 74:259-78. DOI: 10.1016/s0008-6215(00)84781-3. View